Last update 01 Nov 2024

CellionBioMed Inc

South Korea
|
www.cellionbiomed.com

Overview

Basic Info

Introduction
CellionBioMed Inc. is a biopharmaceutical company with a significant scientific foundation, having dedicated many years to research with the aim of decoding the functions of potassium (K+) channels in cell membranes.

Tags

Immune System Diseases
Skin and Musculoskeletal Diseases
Other Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Immune System Diseases6
Nervous System Diseases2
Top 5 Drug TypeCount
Small molecule drug10
Top 5 TargetCount
Potassium channel1
Ion channels1
KCNN4(Intermediate conductance calcium-activated potassium channel protein 4)1

Related

12
Drugs associated with CellionBioMed Inc
BBT-301
Target
Ion channels
Mechanism
Ion channels modulators
Active Org.
CellionBioMed Inc [+2]
Originator Org.
CellionBioMed Inc
Active Indication
Idiopathic Pulmonary Fibrosis
Inactive Indication-
Drug Highest PhasePhase 2
First Approval Ctry. / Loc.-
First Approval Date-
CBM-C1
Target
Potassium channel
Mechanism
Potassium channel blockers
Active Org.
CellionBioMed Inc
Originator Org.
CellionBioMed Inc
Active Indication
Cicatrix [+1]
Inactive Indication-
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date-
CBM-FX
Target
KCNN4
Mechanism
KCNN4 blockers
Active Org.
CellionBioMed Inc
Originator Org.
CellionBioMed Inc
Active Indication
Psoriasis [+2]
Inactive Indication-
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date-
100 Clinical Results associated with CellionBioMed Inc
Login to view more data
0 Patents (Medical) associated with CellionBioMed Inc
Login to view more data
100 Deals associated with CellionBioMed Inc
Login to view more data
100 Translational Medicine associated with CellionBioMed Inc
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 19 Dec 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
7
2
Phase 1 Clinical
Phase 2 Clinical
1
2
Other
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
BBT-301
 ( Ion channels )		Idiopathic Pulmonary Fibrosis
More
Phase 2
CBM-C1
 ( Potassium channel )		Keloid
More
Phase 1
CBM-FX
 ( KCNN4 )		Psoriasis
More
Phase 1
CBM-851
Dermatitis, Atopic
More
Preclinical
CBM-901
Rheumatoid Arthritis
More
Preclinical
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free